Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Vikram
B
B
D004999:Amifostine / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D014987:Xerostomia / Q000139:chemically induced
D011837:Radiation-Protective Agents; D004999:Amifostine